MNKD vs ZYME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
MNKD
ZYME
Investment Advisor Scores
ZYME
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MNKD | ZYME | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 25.7069 | 20.8333 | ZYME |
| PEG Ratio | 4.3866 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 42.9% | -90.6% | MNKD |
| Earnings Growth | -34.9% | 0.0% | ZYME |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.5/100 | 59.2/100 | ZYME |
| Profit Margin | -11.1% | 0.0% | ZYME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | ZYME |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MNKD
NeutralMixed signals - no dominant trend phase, RSI 52
ZYME
NeutralMixed signals - no dominant trend phase, RSI 40
Fundamentals Snapshot
| Metric | MNKD | ZYME |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 31.0 | 29.8 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | -0.9% |
| Gross Margin | 0.8% | -2.5% |
| Operating Margin | 0.0% | -9.2% |
| EPS | -0.15 | -2.02 |
| Dividend Yield | — | — |